Bijlage 1 — Prevalentie-ontwikkeling 2012–2013 per morbiditeitsrisicoklasse per FGK 2013 Beleidsregels vereveningsbijdrage zorgverzekering 2013
Prevalentie-ontwikkeling 2012–2013 per morbiditeitsrisicoklasse per FGK 2013
Bron: College voor zorgverzekeringen
FKG somatisch model
Mannen | 0 | 1 | 2 | 3 | 4 | 5
Leeftijd | Geen FKG | Glaucoom | Schildklieraandoeningen | Psychose, Alzheimer en verslaving | Depressie | Neuropathische pijn
0 t/m 17 | 0,999718 | 1,103468 | 1,076180 | 1,115061 | 1,128787 | 1,035339
18 t/m 29 | 0,999243 | 1,088448 | 1,045733 | 0,997748 | 1,033647 | 1,098684
30 t/m 44 | 0,998047 | 0,984194 | 1,039638 | 1,034106 | 1,040017 | 1,063321
45 t/m 59 | 0,994673 | 1,002219 | 1,039571 | 1,068443 | 1,031860 | 1,043059
60 t/m 74 | 0,982322 | 1,013948 | 1,041829 | 1,071096 | 1,041538 | 1,050655
75 e.o. | 0,965751 | 1,001863 | 1,036500 | 1,072482 | 1,012786 | 0,993264
Vrouwen | 0 | 1 | 2 | 3 | 4 | 5
Leeftijd | Geen FKG | Glaucoom | Schildklieraandoeningen | Psychose, Alzheimer en verslaving | Depressie | Neuropathische pijn
0 t/m 17 | 0,999846 | 1,019773 | 0,998592 | 1,151984 | 1,053967 | 0,944187
18 t/m 29 | 0,998890 | 1,061470 | 1,033880 | 1,017758 | 1,040939 | 0,974125
30 t/m 44 | 0,997259 | 1,072326 | 1,043435 | 1,016593 | 1,020899 | 1,067841
45 t/m 59 | 0,992800 | 0,996174 | 1,034705 | 1,040993 | 1,023214 | 1,030363
60 t/m 74 | 0,982207 | 1,002893 | 1,037420 | 1,054989 | 1,036075 | 1,058459
75 e.o. | 0,979098 | 1,007724 | 1,027912 | 1,081026 | 0,997046 | 0,971499
Mannen | 6 | 7 | 8 | 9 | 10 | 11
Leeftijd | Hoog cholesterol | Diabetes type II zonder hypertensie | COPD/zware astma | Astma | Diabetes type II met hypertensie | Epilepsie
0 t/m 17 | 1,068790 | 1,034109 | 0,966835 | 0,998828 | 0,886496 | 1,035715
18 t/m 29 | 1,040223 | 1,034109 | 1,039389 | 1,010336 | 0,886496 | 1,023074
30 t/m 44 | 1,017903 | 1,030298 | 1,044018 | 1,007116 | 1,079221 | 1,002352
45 t/m 59 | 1,024183 | 1,024344 | 1,066374 | 1,016744 | 1,025499 | 1,008442
60 t/m 74 | 1,050354 | 0,981653 | 1,034878 | 1,013089 | 1,024908 | 1,024577
75 e.o. | 1,091849 | 0,980389 | 1,017063 | 0,993328 | 1,017002 | 1,018356
Vrouwen | 6 | 7 | 8 | 9 | 10 | 11
Leeftijd | Hoog cholesterol | Diabetes type II zonder hypertensie | COPD/zware astma | Astma | Diabetes type II met hypertensie | Epilepsie
0 t/m 17 | 1,107616 | 1,023661 | 1,002291 | 0,998049 | 1,050221 | 1,024595
18 t/m 29 | 1,000253 | 1,023661 | 1,099083 | 0,997636 | 1,050221 | 1,000600
30 t/m 44 | 1,021486 | 1,046387 | 1,042194 | 1,011573 | 0,991278 | 1,003510
45 t/m 59 | 1,042967 | 1,031119 | 1,054380 | 1,029693 | 1,028553 | 1,011110
60 t/m 74 | 1,060316 | 0,983024 | 1,070232 | 1,031798 | 1,008224 | 1,030511
75 e.o. | 1,105586 | 0,949919 | 1,046290 | 1,042638 | 0,989420 | 1,018583
Mannen | 12 | 13 | 14 | 15 | 16 | 17
Leeftijd | Ziekte van Crohn/Colitis Ulcerosa | Hartaandoeningen | Reuma | Parkinson | Diabetes type I | Transplantaties
0 t/m 17 | 1,023977 | 0,978484 | 1,107166 | 1,020173 | 1,023120 | 1,110166
18 t/m 29 | 1,022335 | 1,026759 | 1,035424 | 1,020173 | 1,021266 | 1,021156
30 t/m 44 | 1,005977 | 0,991677 | 1,080538 | 1,020173 | 0,993956 | 1,054310
45 t/m 59 | 1,037986 | 0,975422 | 1,073242 | 1,046671 | 0,998439 | 1,046121
60 t/m 74 | 1,027602 | 0,974986 | 1,092162 | 1,019034 | 1,008092 | 1,039466
75 e.o. | 1,018316 | 0,980111 | 1,055248 | 1,032997 | 1,032343 | 1,066827
Vrouwen | 12 | 13 | 14 | 15 | 16 | 17
Leeftijd | Ziekte van Crohn/Colitis Ulcerosa | Hartaandoeningen | Reuma | Parkinson | Diabetes type I | Transplantaties
0 t/m 17 | 1,026042 | 0,857223 | 1,070574 | 1,081991 | 1,011733 | 1,040573
18 t/m 29 | 0,969310 | 1,047371 | 1,085957 | 1,081991 | 1,044446 | 1,026607
30 t/m 44 | 1,026352 | 1,004070 | 1,067059 | 1,081991 | 0,988232 | 1,058118
45 t/m 59 | 1,038695 | 0,982225 | 1,071679 | 1,017931 | 0,995372 | 1,057924
60 t/m 74 | 1,069441 | 0,979959 | 1,074935 | 1,011400 | 0,986291 | 1,051651
75 e.o. | 1,027720 | 0,976367 | 1,079724 | 1,036162 | 1,003068 | 1,103433
Mannen | 18 | 19 | 20 | 21 | 22 | 23 | 24
Leeftijd | Cystic fibrosis/pancreasenzymen | Aand. van hersenen/ruggemerg | Kanker | Hormoongevoelige tumoren | HIV/AIDS | Nieraandoeningen | Groeihormonen
0 t/m 17 | 0,975817 | 0,971736 | 0,788487 | 1,053760 | 1,122961 | 0,972784 | 1,054729
18 t/m 29 | 1,043966 | 0,971736 | 1,099803 | 1,053760 | 1,187398 | 0,972784 | 1,017973
30 t/m 44 | 1,042147 | 1,062215 | 1,087515 | 0,951838 | 1,058101 | 0,977046 | 1,016369
45 t/m 59 | 0,998555 | 1,073000 | 1,066420 | 1,004480 | 1,113948 | 0,999226 | 0,957358
60 t/m 74 | 1,069397 | 1,092396 | 1,034424 | 1,003191 | 1,178061 | 0,975536 | 1,039715
75 e.o. | 1,073752 | 1,069907 | 1,073379 | 1,012391 | 1,150632 | 0,967737 | 1,039715
Vrouwen | 18 | 19 | 20 | 21 | 22 | 23 | 24
Leeftijd | Cystic fibrosis/pancreasenzymen | Aand. van hersenen/ruggemerg | Kanker | Hormoongevoelige tumoren | HIV/AIDS | Nieraandoeningen | Groeihormonen
0 t/m 17 | 0,960673 | 1,025958 | 1,238943 | 1,083221 | 1,057974 | 0,886372 | 1,051110
18 t/m 29 | 0,983893 | 1,025958 | 1,179182 | 1,100643 | 1,000567 | 0,886372 | 0,964612
30 t/m 44 | 1,100903 | 1,025650 | 1,099133 | 1,041935 | 1,071376 | 0,943136 | 1,003352
45 t/m 59 | 0,968003 | 1,074712 | 1,049646 | 1,043533 | 1,140072 | 0,941525 | 1,034380
60 t/m 74 | 1,082373 | 1,064369 | 0,995114 | 1,064317 | 1,188780 | 0,945714 | 1,014630
75 e.o. | 1,082083 | 1,070487 | 1,028741 | 1,010350 | 1,188780 | 1,005590 | 1,014630
FKG GGZ model
Mannen | 0 | 1 | 2 | 3 | 4 | 5
Leeftijd | Geen FKG GGZ | Psychose | Psychose depot | Stemmingstoornis | Verslaving | Bipolaire stoornis reg.
0 t/m 17 | 0,998027 | 1,117450 | 0,968740 | 1,113914 | 0,958307 | 0,866978
18 t/m 29 | 0,998789 | 1,005152 | 0,968740 | 1,026146 | 0,958307 | 0,866978
30 t/m 44 | 0,998371 | 1,038790 | 0,997696 | 1,036390 | 1,023389 | 1,010568
45 t/m 59 | 0,998105 | 1,068791 | 1,022281 | 1,036134 | 1,084257 | 0,964035
60 t/m 74 | 0,998307 | 1,075171 | 1,063003 | 1,045307 | 1,114882 | 1,003139
75 e.o. | 0,999414 | 1,075460 | 0,968953 | 1,016464 | 1,338917 | 0,988236
Vrouwen | 0 | 1 | 2 | 3 | 4 | 5
Leeftijd | Geen FKG GGZ | Psychose | Psychose depot | Stemmingstoornis | Verslaving | Bipolaire stoornis reg.
0 t/m 17 | 0,999153 | 1,134171 | 1,008658 | 1,064999 | 0,872436 | 0,909147
18 t/m 29 | 0,998645 | 1,024530 | 1,008658 | 1,036910 | 0,872436 | 0,909147
30 t/m 44 | 0,998670 | 1,022096 | 0,984263 | 1,019318 | 0,966590 | 0,915676
45 t/m 59 | 0,997841 | 1,059234 | 0,969721 | 1,026280 | 1,007503 | 0,947124
60 t/m 74 | 0,997613 | 1,058860 | 0,999560 | 1,037412 | 1,089451 | 0,953401
75 e.o. | 0,999756 | 1,024159 | 0,938793 | 1,004217 | 1,257659 | 0,961756
Mannen | 6 | 7
Leeftijd | Bipolaire stoornis compl. | ADHD
0 t/m 17 | 1,054845 | 1,090344
18 t/m 29 | 1,054845 | 1,167897
30 t/m 44 | 0,960484 | 1,170574
45 t/m 59 | 1,012448 | 1,157906
60 t/m 74 | 1,020521 | 1,212823
75 e.o. | 0,979485 | 0,918835
Vrouwen | 6 | 7
Leeftijd | Bipolaire stoornis compl. | ADHD
0 t/m 17 | 1,038369 | 1,164863
18 t/m 29 | 1,038369 | 1,208419
30 t/m 44 | 1,012425 | 1,222916
45 t/m 59 | 1,048032 | 1,232612
60 t/m 74 | 1,008917 | 1,196263
75 e.o. | 1,012814 | 1,196263
- Regeling
- Beleidsregels vereveningsbijdrage zorgverzekering 2013
- Soort
- ZBO-regeling
- Geldend vanaf
- 01-10-2014
- BWB-id
- BWBR0032997
- Versie
- 2014-10-01_0